Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial

Woo Se Joon and Sadda SriniVas R and Bradvica Mario and Vajas Attila and Sagong Min and Ernest Jan and Studnička Jan and Veith Miroslav and Wylegala Edward and Patel Sunil and Yun Cheolmin and Orski Michal and Astakhov Sergei and Tóth-Molnár Edit and Csutak Adrienne and Enyedi Lajos and Choi Wooree and Oh Inkyung and Jang Hyerin: Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial.
BMJ OPEN OPHTHALMOLOGY, 8 (1). ISSN 2397-3269 (2023)

[thumbnail of BMJ.pdf] Text
BMJ.pdf - Published Version

Download (695kB)
Item Type: Journal Article
Journal or Publication Title: BMJ OPEN OPHTHALMOLOGY
Date: 2023
Volume: 8
Number: 1
Number of Pages: 10
Publication identifier: e001561
ISSN: 2397-3269
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 34477400
DOI azonosító: https://doi.org/10.1136/bmjophth-2023-001561
Date Deposited: 2024. May. 06. 10:46
Last Modified: 2024. May. 06. 10:46
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/30469
Web of Science® Times Cited: 3 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year